[1] Nabhan F,Dedhia PH,Ringel Matthew D.Thyroid cancer,recent advances in diagnosis and therapy[J].Int J Cancer,2021,149(5):984~992.
[2] VargoMM.Brain Tumors and Metastases[J].Phys Med Rehabil Clin N Am,2017,28(1):115~141.
[3] Ostrom QT,Wright CH,Barnholtz-SloanJS.Brain metastases:epidemiology [J].Handb Clin Neurol,2018,149:27~42.
[4] CagneyDN,MartinAM,CatalanoPJ,et al.Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy:A population-based study [J].Neuro Oncol,2017,19(11):1511~1521.
[5] Nigam A,Singh AK,Sing SK,et al.Skull metastasis in papillary carcinoma of thyroid:A case report[J].World J Radiol,2012,4(6):286~290.
[6] Mydlarz WK,Wu J,Aygun N,et al.Management considerations for differentiated thyroid carcinoma presenting as a metastasis to the skull base[J].Laryngoscope,2007,117(7):1146~1152.
[7] Matsuno A,Murakami M,Hoya K,et al.Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma[J].Acta Histochem Cytochem,2013,46(5):129~136.
[8] MuccioCF,TedeschiE,UggaL,et al.Solitary Cerebral Metastases vs.High-grade Gliomas:Usefulness of Two MRI Signs in the Differential Diagnosis[J].Anticancer Res,2019,39(9):4905~4909.
[9] SunQ,LiM,WangG,et al.Distribution of metastasis in the brain in relation to the hippocampus:a retrospective single-center analysis of 565 metastases in 116 patients [J].Cancer Imaging,2019,19(1):1~9.
[10] 杨婷婷,黄文涛,张惠箴,等.去分化软骨肉瘤40例临床病理特征与预后分析 [J].临床与实验病理学杂志,2018,34(3):278~283.
[11] 韩长年.软骨肉瘤的MRI强化特点[J].磁共振成像,2020,11(8):675~676,687.
[12] Robert-Boire V,Rosca L,Samson Y,et al.Clinical presentation and outcome of patients with optic pathway glioma[J].Pediatr Neurol,2017,75:55~60.
[13] Marsault P,Ducassou S,Menut F,et al.Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children[J].Neuroradiology,2019,61(6):711~720.
[14] Fried I,Tabori U,Tihan T,et al.Optic pathway gliomas:a review[J].CNS Oncol,2013,2(2):143~159.
[15] 刘兆会,何雪颖,陈青华,等.颅眶沟通性脑膜瘤的影像学分析[J].医学影像学杂志,2019,29(5):713~716.
[16] MaoJF,XiaXB,TangXB,et al.Analyses on the misdiagnoses of 25 patients with unilateral optic nerve sheath meningioma[J].Int J Ophthalmol,2016,9(9):1315~1319.
[17] ArkerRT,OvensCA,FraserCL,et al.Optic nerve sheath meningiomas:prevalence,impact,and management strategies[J].Eye Brain,2018,10:85~99.
[18] 白惠玲,马建民,刘勤,等.侵犯骨质的特发性眼眶炎性假瘤诊疗一例[J].中华实验眼科杂志,2021,39(1):52~53.
[19] 李海燕,王道芸,黄莉.眼眶炎性假瘤多层螺旋CT、磁共振影像学表现及诊断价值研究[J].中国CT和MRI杂志,2021,19(10):22~24.
[20] 杨立娟,谢小洋,张晖,等.MRI特征在鉴别眼眶淋巴瘤与炎性假瘤中的诊断价值[J].实用放射学杂志,2021,37(7):1056~1059,1135.
[21] 乔婕,高恺明,王虎,等.发生于颅眶交界区伴溶骨性改变的B小细胞淋巴瘤/慢性淋巴细胞白血病[J].中国现代神经疾病杂志,2016,16(8):497~502.
[22] Nussbaum ES,Djalilian HR,Cho KH,et al.Brain metastases.Histology,multiplicity,surgery,and survival[J].Cancer,2015,78(8):1781~1788.
[23] 陈卓,邱前辉,张秋航,等.以颅底转移为首发症状的分化型甲状腺癌的3例报告伴文献复习[J].临床耳鼻咽喉头颈外科杂志,2017,31(11):881~884.
[24] 庞其军,赵颖.表现为中颅窝底颅内外沟通性占位的甲状腺癌脑转移瘤三例[J].中华行为医学与脑科学杂志,2014,23(5):440~441.
[25] 罗一宁,陈露,吴嘉铭,等.分化型甲状腺癌颅骨和脑转移各一例报道并文献复习[J].中华神经医学杂志,2021,20(4):398~400.
[26] 刘丕楠,王忠诚,吴胜田,等.颅底沟通性肿瘤的外科治疗[J].中华神经外科杂志,2006(1):32~35.
[27] KimK,IbrahimAM,KoolenPG,et al.Analysis of morbidity and mortality in patients undergoing skull base reconstruction[J].J Craniofac Surg,2015,26(1):135~140.
[28] Abu-Ghanem S,Ben-Cnaan R,Leibovitch I,et al.Outcomes of endonasal endoscopic dacryocystorhinostomy after maxillectomy in patients with paranasal sinus and skull base tumors[J].European Archives of Oto-Rhino-Laryngology,2014,271(6):1513~1518.
[29] 董浩,李永,邱锷,等.鼻内镜联合显微外科手术治疗前中颅底沟通性肿瘤的手术疗效分析(附38例报告)[J].中华神经外科杂志,2020,36(7):722~725.
[30] 殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2007:149~156.
[31] 王庆兰,李敬芳,孙小英,等.高放射剂量对甲状腺癌脑转移患者生存期及肿瘤标志物水平的影响[J].实用临床医药杂志,2017,21(11):186~188.
[32] FA Verburg.Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma[J].Quarterly Journal of Nuclear Medicine and Molecular Imaging,2019,63(3):253~257.
[33] Xu Lu,Liu Qiong,Liu Ying,et al.Parameters Influencing curative effect of 131I therapy on pediatric differentiated thyroid carcinoma:A retrospective study[J].Med Sci Monit,2016,22:3079~3085.
[34] Sheu NW,Jiang HJ,Wu CW,et al.Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma:case reports and literature review[J].European Arch Oforhino Laryngol,2019,17(1):84~91. |
